EPS创健科技与誉辰医疗达成谅解备忘录,拟收购华大基因16.23%股权

美股速递
Feb 03

EPS创健科技集团宣布,已与誉辰医疗签署谅解备忘录,计划收购后者持有的华大基因16.23%股权。此次战略合作旨在深化双方在基因技术领域的布局,通过资源整合提升市场竞争力。若交易顺利完成,将显著增强EPS创健科技在精准医疗赛道的影响力,为其长期发展注入新动能。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10